Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p63
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 63/66)
Character Range: 208520–211541

treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).
V15996  Fentanyl   Authorities for increased maximum quantities and/or repeats under this restriction must only be considered for chronic severe disabling pain where the total duration of non-PBS and PBS opioid analgesic treatment is less than 12 months.
        Methadone  Authority requests extending treatment duration up to 1 month may be requested through the Online PBS Authorities system or by calling Services Australia. Authority requests extending treatment duration beyond 1 month may be requested through the Online PBS Authorities system or in writing and must not provide a treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).
V16000  Fentanyl   Authorities for increased maximum quantities and/or repeats must only be considered for chronic severe disabling pain where the patient has received initial authority approval and the total duration of non-PBS and PBS opioid analgesic treatment: (i) is less than 12 months; or (ii) exceeds 12 months and the palliative care patient is unable to have annual pain management review due to their clinical condition; or (iii) exceeds 12 months and the patient's clinical need for continuing opioid treatment has been confirmed through consultation with the patient by another medical practitioner or a palliative care nurse practitioner in the past 12 months; or (iv) has exceeded 12 months prior to 1 June 2020 and the patient's pain management and clinical need for continuing opioid treatment has not been confirmed through consultation with the patient by another medical practitioner or a palliative care nurse practitioner in the past 12 months, but is planned in the next 3 months.
        Methadone  Authority requests extending treatment duration up to 1 month may be requested through the Online PBS Authorities system or by calling Services Australia. Authority requests extending treatment duration beyond 1 month may be requested through the Online PBS Authorities system or in writing and must not provide a treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).

[417] Schedule 5, entry for Amiodarone in the form Tablet containing amiodarone hydrochloride 200 mg
omit from the column headed "Brand": APO-Amiodarone
[418] Schedule 5, entry for Amitriptyline in the form Tablet containing amitriptyline hydrochloride 25 mg
omit from the column headed "Brand": APO-Amitriptyline 25
[419] Schedule 5, entry for Amitriptyline in the form Tablet containing amitriptyline hydrochloride 10 mg
omit from the column headed "Brand": APO-Amitriptyline 10
[420] Schedule 5, entry for Amitriptyline in the form Tablet containing amitriptyline hydrochloride 50 mg
omit from the column headed "Brand": APO-Amitriptyline 50
[421] Schedule 5, entry for Atenolol
omit from the column headed "Brand": APO-Atenolol
[422] Schedule 5, entry for